Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway by Piatkov, Konstantin I. et al.
Calpain-generated natural protein fragments as
short-lived substrates of the N-end rule pathway
Konstantin I. Piatkov, Jang-Hyun Oh, Yuan Liu1, and Alexander Varshavsky2
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125
Contributed by Alexander Varshavsky, January 28, 2014 (sent for review January 18, 2014)
Calpains are Ca2+-dependent intracellular proteases. We show
here that calpain-generated natural C-terminal fragments of pro-
teins that include G protein–coupled receptors, transmembrane
ion channels, transcriptional regulators, apoptosis controllers,
kinases, and phosphatases (Phe-GluN2a, Lys-Ica512, Arg-Ankrd2,
Tyr-Grm1, Arg-Atp2b2, Glu-Bak, Arg-Igfbp2, Glu-IκBα, and Arg-c-
Fos), are short-lived substrates of the Arg/N-end rule pathway,
which targets destabilizing N-terminal residues. We also found
that the identity of a fragment’s N-terminal residue can change
during evolution, but the residue’s destabilizing activity is virtually
always retained, suggesting selection pressures that favor a short
half-life of the calpain-generated fragment. It is also shown that
a self-cleavage of a calpain can result in an N-end rule substrate.
Thus, the autoprocessing of calpains can control them by making
active calpains short-lived. These and related results indicate that
the Arg/N-end rule pathway mediates the remodeling of oligo-
meric complexes by eliminating protein fragments that are pro-
duced in these complexes through cleavages by calpains or other
nonprocessive proteases. We suggest that this capability of the
Arg/N-end rule pathway underlies a multitude of its previously
known but mechanistically unclear functions.
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Calpains are a family of intracellular proteases that have incommon their dependence on Ca2+, their belonging to the
superfamily of cysteine proteases, and their ability to make
a small number of specific cuts in their natural protein substrates
(1–3). Of the 14 distinct human calpains, the ubiquitously ex-
pressed calpain-1 (μ-calpain) and calpain-2 (m-calpain) are the
major species. Natural calpain substrates were identified thus far
largely by serendipity, as distinguished from proteome-scale
surveys. The number of known calpain substrates in mammals is
roughly 200. Calpain-mediated cuts have been accurately map-
ped in fewer than 100 of these proteins. The actual diversity of
calpain substrates encoded by a mammalian genome is unknown.
It may significantly exceed 1,000 different proteins (2).
The functions of calpains are many and stem from calpain-
mediated cleavages of specific proteins at defined positions,
usually within unstructured loops (1, 2). These cleavages are
controlled by the levels of Ca2+, by phosphorylation of calpains
and/or their substrates, by natural calpain inhibitors such as
calpastatin (4), and by a regulated localization (e.g., membrane
localization) of specific calpains. For example, cell movements
involve calpain-mediated, spatiotemporally controlled cleavages
of cytoskeletal proteins (5). Proteolysis by calpains plays many
other roles as well, including their major functions in the brain
and muscle (6–8). Despite the obvious biological importance
of calpains, the functional understanding of calpain-generated
specific protein fragments and their effects on oligomeric protein
complexes (in which these fragments are formed and initially
reside) is just beginning.
In vivo cleavages of cytosolic and nuclear proteins by non-
processive proteases such as separases, caspases, and (some)
deubiquitylases can generate C-terminal fragments that bear
destabilizing N-terminal residues, i.e., the ones that can be rec-
ognized by the N-end rule pathway, a processive proteolytic
system. These fragments have been shown to be short-lived
N-end rule substrates, with either demonstrated or predicted
functional ramifications (9–14). In the present work, we extended
these insights to a number of natural calpain substrates, thereby
linking the N-end rule pathway to biological consequences of
calpain activity.
The N-end rule pathway recognizes proteins containing
N-terminal degradation signals called N-degrons, polyubiquitylates
these proteins, and thereby causes their degradation by the pro-
teasome (Fig. 1) (9, 11, 12, 14–23). The main determinant of an
N-degron is a destabilizing N-terminal residue of a protein.
Recognition components of the N-end rule pathway are called
N-recognins. In eukaryotes, N-recognins are E3 ubiquitin (Ub)
ligases that can target N-degrons (Fig. 1).
Regulated degradation of proteins or their fragments by the
N-end rule pathway mediates a strikingly broad range of bi-
ological functions, including the sensing of heme, NO, oxygen,
and short peptides; the control, through subunit-selective deg-
radation, of the input stoichiometries of subunits in oligomeric
protein complexes; the elimination of misfolded or otherwise
abnormal proteins; the degradation of specific proteins after
their retrotranslocation to the cytosol from mitochondria or
other membrane-enclosed compartments; the repression of ap-
optosis and neurodegeneration; the regulation of chromosome
transcription, repair, replication, and cohesion/segregation; the
regulation of G proteins, autophagy, peptide import, meiosis,
immunity, fat metabolism, cell migration, actin filaments, cardio-
vascular development, spermatogenesis, neurogenesis, and memory;
and the regulation of many processes in plants (Fig. 1 and SI Text).
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In eukaryotes, the N-end rule pathway consists of two branches.
One of them, called the Arg/N-end rule pathway, targets specific
unacetylated N-terminal residues (Fig. 1A) (11, 15, 23). The pri-
mary destabilizing N-terminal residues Arg, Lys, His, Leu, Phe, Tyr,
Trp, and Ile are directly recognized by N-recognins. In contrast,
N-terminal Asn, Gln, Asp, and Glu (as well as Cys under some
metabolic conditions) are destabilizing owing to their preliminary
enzymatic modifications, which include Nt-deamidation and Nt-
arginylation (Fig. 1A). In the yeast Saccharomyces cerevisiae, the
Arg/N-end rule pathway is mediated by the Ubr1 N-recognin,
a 225-kDa RING-type E3 Ub ligase and a part of the targeting
complex comprising the Ubr1-Rad6 and Ufd4-Ubc4/5 holoenzymes
(9, 16, 19). In multicellular eukaryotes, several E3 Ub ligases (in-
cluding Ubr1) function as N-recognins of the Arg/N-end rule
pathway (Fig. 1A). It was recently shown that both yeast and
mammalian Ubr1 can recognize not only the unacetylated pri-
mary destabilizing N-terminal residues cited above, but also the
unacetylated N-terminal Met residue, if it is followed by a hy-
drophobic residue. This capability of the Arg/N-end rule pathway
greatly expands the range of its substrates, as virtually all nascent
proteins bear N-terminal Met (23).
The other branch, called the Ac/N-end rule pathway, recognizes
proteins through their Nα-terminally acetylated (Nt-acetylated)
residues (Fig. 1B) (17, 23, 24). The degradation signals and E3 Ub
ligases of the Ac/N-end rule pathway are called Ac/N-degrons and
Ac/N-recognins, respectively. Nt-acetylation of cellular proteins
is apparently irreversible, in contrast to acetylation-deacetylation
of internal Lys residues. The bulk of Nt-acetylation is cotransla-
tional, being mediated by ribosome-associated Nt-acetylases. Ap-
proximately 90% of human proteins are Nt-acetylated (25, 26).
Many, possibly most, Nt-acetylated proteins contain Ac/N-degrons
(Fig. 1B) (17, 23, 24).
Our surveys of the previously characterized natural calpain
substrates in mammals identified ∼50 proteins (about 40% of
the total number of actually mapped substrates) whose calpain-
generated C-terminal fragments bear destabilizing N-terminal resi-
dues recognized by the Arg/N-end rule pathway. These proteins
include transcriptional and translational regulators, transmembrane
ion channels, cytoskeletal proteins, kinases, phosphatases, and other
enzymes (Fig. 2). We selected from this set, essentially at random,
11 natural fragments (Phe1279-GluN2a, Lys609-Ica512, Arg103-
Ankrd2, Tyr937-Grm1, Arg1091-Atp2b2,Glu16-Bak, Arg181-Igfbp2,
Glu51-IκBα, Arg91-c-Fos, Asp142-Capns1, and Leu28-Capn1) (Fig.
2, #1 and #4–13) and examined them for actually being N-end rule
substrates. It should be noted that none of the earlier studies that
initially described these or other calpain-generated protein frag-
ments considered the possibility of their regulation through degra-
dation by the N-end rule pathway.
We show here that all of these fragments are, in fact, short-lived
substrates of the Arg/N-end rule pathway. As discussed below,
calpains join other proteases, including Met-aminopeptidases,
separases and caspases, as substrate-generating upstream compo-
nents of the Arg/N-end rule pathway (Fig. 1A). Specifically,
cleavages by these and other nonprocessive proteases can produce
Fig. 1. The mammalian N-end rule pathway. See Introduction for descriptions of the pathway’s mechanistic aspects and biological functions. N-terminal residues
are denoted by single-letter abbreviations. A yellow oval denotes the rest of a protein substrate. (A) The Arg/N-end rule pathway. It recognizes proteins through
their specific unacetylated N-terminal residues (9, 19). (B) The Ac/N-end rule pathway. It recognizes proteins through their Nα-terminally acetylated (Nt-acetylated)
residues (17, 23, 24). Red arrow on the left indicates the removal of the N-terminal Met residue by Met-aminopeptidases (MetAPs). N-terminal Met is retained
if a residue at position 2 is larger than Val (56). See SI Text for a detailed supplementary legend and supplementary references to this figure.
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protein-size fragments that bear active N-degrons. We discuss the
biological ramifications of this advance and the resulting connection
between the Arg/N-end rule pathway and the functions of calpains.
Results
Destabilizing N-Terminal Residues of Calpain-Generated Fragments.
A P1′ residue of a cleavage site is the residue that becomes
N-terminal upon cleavage. The identities of P1′ residues in
full-length proteins that give rise to the Arg91-c-Fos, Lys609-
Ica512, Arg1091-Atp2b2, and Leu28-Capn1 fragments were un-
changed during evolution of examined vertebrates (Fig. S1 A, B, D,
and E). In contrast, N-terminal Arg of the Arg103-Ankrd2 fragment
is conserved among mammals and birds but changes to Lys in
amphibians (Fig. 3E). N-terminal Glu ofGlu16-Bak is conserved in
humans, dogs, cows, and bats, but changes to Asp in hamsters and
manatees and to Lys in armadillos and bonobos (Pan paniscus),
a species of chimpanzee (Fig. 3A). Remarkably, this residue of
Bak is Glu (i.e., the same as in human Glu16-Bak) in the other
chimpanzee species, Pan troglodytes, strongly suggesting that the
Glu16→Lys16 mutation in Bak of P. paniscus occurred after
divergence of these chimpanzee lineages, i.e., less than 2 Mya
(Fig. 3A). N-terminal Asp of Asp143-Capns1 is conserved in
vertebrates other than fishes but changes to Glu in fishes
(Fig. 3F). N-terminal Arg of Arg181-Igfbp2 is conserved from
mammals to fishes but changes to Lys in lizards (Fig. S1C).
N-terminal Glu of Glu51-IκBα is conserved among mammals and
fishes but changes to Asp in chickens and to Asn in amphibians
(Fig. 3C). N-terminal Tyr of Tyr937-Grm1 is conserved in most
vertebrates but changes to Phe in armadillos and to His in
Jaculus, a family of small rodents (Fig. 3B). N-terminal Phe of
mouse Phe1279-GluN2a changes to Leu in humans, cows, and
platypuses, to Tyr in chickens, and to His in turtles (Fig. 3D).
Fig. 2. Calpain-generated C-terminal fragments of mammalian proteins that are identified or predicted substrates of the Arg/N-end rule pathway. The
entries whose numbers are in green are the experimentally characterized and validated (most of them in the present study) substrates of the Arg/N-end rule
pathway. The entries whose numbers are in black are predicted Arg/N-end rule substrates. Each entry cites a calpain-generated C-terminal fragment of
a protein and the fragment’s N-terminal residue (using three-letter abbreviations for amino acids), followed by a description of uncleaved (full-length)
precursor protein. A calpain cleavage site, denoted by an arrowhead, is denoted using single-letter abbreviations for amino acids. An enlarged P1′ residue (in
red) becomes N-terminal on the cleavage. The indicated residue numbers are the number of the first shown residue of a full-length protein and the number
of its last residue, respectively. All entries are mouse proteins, with the exception of #14 and #27, which are human proteins. See SI Text for a detailed
supplementary legend to this data-rich figure.














Remarkably, this seeming jumble of evolutionary changes of
P1′ residues in calpain substrates (Fig. 3 and Fig. S1) exhibits
a telling constraint: all of the above P1′ residues (future N-ter-
minal residues), including the ones that became altered during
evolution, are destabilizing in the Arg/N-end rule pathway (Fig.
1A). In other words, the observed changes of P1′ residues in
these calpain substrates always retained the ability of a frag-
ment’s N-terminal residue to be targeted by the Arg/N-end rule
pathway (Figs. 1A and 3 and Fig. S1). A constraint of this kind
would be expected if a short in vivo half-life of a fragment (rather
than the exact identity of its N-terminal residue) is a fitness-
increasing property of this fragment, favored by natural selection.
Calpain-Generated Protein Fragments as N-End Rule Substrates.
Previous analyses of cleavage sites in calpain substrates were
performed in vitro, using purified calpains and (usually) higher
concentrations of Ca2+ than the physiologically relevant (low
micromolar) calpain-activating levels of Ca2+. These analyses
indicated that some proteins can be cleaved in vitro by calpains
at multiple sites (typically two, occasionally three or more). In
such cases only one, usually the predominant site, was examined
in the present study (Figs. 4 and 5). In vivo, the same proteins
would encounter lower levels of calpains and lower durations of
calpain-activating concentrations of Ca2+. In addition, natural
calpain substrates are usually subunits of oligomeric complexes.
For all these reasons, calpain-mediated cleavages of proteins in
vivo are likely to be more confined in extent and scope than the
observed in vitro cleavages. Having mentioned limitations of in
vitro analyses, we should emphasize that all calpain-generated
fragments cited in Fig. 2 have been detected in vivo as well
(Introduction).
The N-end rule degradation assays used the Ub reference tech-
nique (URT) (Fig. 4A) (27). The cotranslational cleavage of a
URT-based fusion by deubiquitylases produces, at the initially
equimolar ratio, a test protein with a desired N-terminal residue
and a reference protein such as fDHFR-UbR48, a flag-tagged de-
rivative of dihydrofolate reductase (Fig. 4A). In URT-based assays,
a labeled test protein is quantified by measuring its level relative to
the level of a stable reference at the same time point (12, 14).
URT-based 35S-pulse-chases were performed in a transcrip-
tion-enabled rabbit reticulocyte extract, which has been exten-
sively used to analyze the Arg/N-end rule pathway (9). Specific
URT fusions were labeled with 35S-Met/Cys for 10 min at 30 °C,
followed by a chase, immunoprecipitation with anti-flag antibody,
SDS/PAGE, autoradiography, and quantification (Figs. 4 and 5).
The logic of these assays involves a comparison between the
degradation rates of a protein bearing a destabilizing N-terminal
residue and an otherwise identical protein with an N-terminal
Fig. 3. Evolutionary conservation of destabilizing activity of P1′ residues in calpain cleavage sites. Arrowheads indicate calpain cleavage sites. P1′ residues,
which become N-terminal upon the cleavage, are larger and colored. The diagrams and indicated residue numbers are of mouse [Mus musculus (Mm)]
proteins. (A) Bak. (B) Grm1. (C) IκBα. (D) GluN2a. (E) Ankrd2. (F) Capsn1. See the main text for descriptions of these proteins and the drift-with-constraint
evolutionary patterns of P1′ residues in calpain cleavage sites.
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residue such as Val, which is not recognized by the Arg/N-end
rule pathway (Fig. 1A). In addition to being more accurate
than pulse-chases without a stable reference, URT makes it
possible to measure the degradation of a test protein during the
pulse, i.e., before the chase (12, 14).
Phe1279-GluN2a.GluN2a (NMDA-R2a) is a subunit of the NMDA
receptor (NMDAR), a glutamate receptor that can function as
a ligand-gated Ca2+ channel (28). The 23-kDa calpain-generated
mouse Phe1279-GluN2a fragment (Figs. 2, #13, and 3D) (29) was
short-lived in reticulocyte extract (initial postpulse t1/2 of ∼8 min),
Fig. 4. The Phe-GluN2a, Lys-Ica512, Arg-Ankrd2, Tyr-Grm1, and Arg-Atp2b2 fragments as short-lived substrates of the Arg/N-end rule pathway. The mo-
lecular mass values for untagged test proteins were ∼1 kDa smaller than their indicated sizes, as these fragments contained the ∼1-kDa flag epitope. Des-
ignations are as in Fig. 1. (A) The ubiquitin reference technique (URT). (B) Phe1279-GluN2a. (C) Quantification of data in B. (D) Lys609-Ica512. (E)
Quantification of data in D. (F) Arg103-Ankrd2. (G) Quantification of data in F. (H) Tyr937-Grm1. (I) Quantification of data in H. (J) Arg1091-Atp2b2. (K)
Quantification of data in J.
Fig. 5. The Asp-Capns1, Leu-Capn1, Glu-Bak, Arg-Igfbp2, Glu-IκBα, and Arg-c-Fos fragments as short-lived substrates of the Arg/N-end rule pathway. Des-
ignations are as in Figs. 1 and 3. (A) Asp142-Capns1. (B) Quantification of data in A. (C) Leu28-Capn1. (D) Quantification of data in C. (E) Glu16-Bak. (F)
Quantification of data in E. (G) Arg181-Igfbp2. (H) Quantification of data in G. (I) Glu51-IκBα. (J) Quantification of data in I. (K) Arg91-c-Fos. (L) Quantification
of data in K.














in striking contrast to the otherwise identical Val1279-GluN2a
fragment, which was nearly completely stable (Fig. 4 B and C).
Moreover, ∼90% of 35S-labeled Phe1279-GluN2a was degraded
by the Arg/N-end rule pathway before the chase (during the 10-min
pulse), in contrast to Val1279-GluN2a (Fig. 4C).
Lys609-Ica512. Ica512 (Ptprn) is a member of the receptor protein
phosphatase (PTP) family of integral membrane proteins, except
that the cytosolic domain of Ica512 lacks phosphatase activity
(30). Ica512 is expressed largely in neurons and neuroendocrine
cells and is a major target of autoreactive antibodies in type I
diabetes. The 43-kDa calpain-generated mouse Lys609-Ica512
fragment (Fig. 2, #12, and Fig. S1D) enters the nucleus and acts
as a transcriptional regulator (30, 31). Lys609-Ica512 was short-
lived in reticulocyte extract (postpulse t1/2 of ∼6 min), in contrast
to Val609-Ica512, which was completely stable (Fig. 4 D and E).
Moreover, ∼75% of 35S-labeled Lys609-Ica512 was degraded
before the chase, in contrast to Val609-Ica512 (Fig. 4E).
Arg103-Ankrd2.Ankrd2 (Marp2, Arpp) is a member of the MARP
(muscle ankyrin repeat protein) family. Ankrd2 is preferentially
expressed in the skeletal and cardiac muscle and functions as
a negative regulator of muscle differentiation (32). The 30-kDa
calpain-generated mouse Arg103-Ankrd2 fragment (Figs. 2, #10,
and 3E) (33) was short-lived in reticulocyte extract (initial
postpulse t1/2 of ∼5 min), in contrast to Val103-Ankrd2, which
was nearly completely stable (Fig. 4 F and G). In addition, ∼94%
of 35S-labeled Arg103-Ankrd2 was degraded by the Arg/N-end
rule pathway before the chase, in contrast to Val103-Ankrd2
(Fig. 4G).
Tyr937-Grm1. Grm1 (mGluR1α, mGlu1α) is an isoform of a
member of the group I subfamily of metabotropic glutamate re-
ceptors (mGluRs). Grm1 is activated by glutamate, couples to
Gq-type G proteins, and mediates a variety of functions, in-
cluding (indirectly) Ca2+ transients (34). The 30-kDa calpain-
generated mouse Tyr937-Grm1 fragment (Figs. 2, #11, and 3B)
(35) was short-lived in reticulocyte extract (postpulse t1/2 of ∼45
min), in contrast to Val937-Grm1, which was stable (Fig. 4 H and
I). One illustration of differences among the proteins charac-
terized in this study was the slower (but still entirely N-end rule
specific) degradation of Tyr937-Grm1, whose t1/2 of ∼45 min
(Fig. 4 H and I) was at least fivefold longer than the half-lives of
other calpain-generated Arg/N-end rule substrates (Fig. 4 B–G).
In addition, little degradation of this fragment was observed
before the chase (Fig. 4I), in contrast to the massive prechase
degradation (75–94%) of more unstable N-end rule substrates
(Fig. 4 C, E, and G).
Arg1091-Atp2b2. The plasma membrane Ca2+ ATPase (PMCA) is
a transmembrane pump that ejects Ca2+ from the cytosol to ex-
tracellular space and is encoded by the functionally overlapping
Atp2b1-Atp2b4 genes (36). The 13-kDa calpain-generated mouse
Arg1091-Atp2b2 fragment (Fig. 2, #8, and Fig. S1E) (37) was
short-lived in reticulocyte extract (initial postpulse t1/2 of ∼5 min),
in contrast to Val1091-Atp2b2, which was nearly completely stable
(Fig. 4 J and K). In addition, ∼89% of 35S-labeled Arg1091-Atp2b2
was degraded before the chase, in contrast to Val1091-Atp2b2
(Fig. 4K).
Glu16-Bak. Bak is a conditionally proapoptotic member of the Bcl-2
superfamily of apoptosis regulators. Owing to its C-terminal
transmembrane domain, Bak resides in the outer mitochondrial
and ER membranes. Under proapoptotic conditions, Bak con-
tributes to the mitochondrial outer membrane permeabilization
(MOMP), which can result in apoptosis (38). The proapoptotic
cleavage of Bak by calpains generates the 16-kDa Glu16-Bak
fragment lacking the 15-residue N-terminal region of Bak that
appears to interact with membranes in full-length Bak (39).
Mouse Glu16-Bak (Figs. 2, #1, and 3A) was short-lived in re-
ticulocyte extract (initial postpulse t1/2 of ∼20 min), in contrast to
Val16-Bak, which was still unstable but to a much lower extent
than Glu16-Bak (postpulse t1/2 > 2 h), indicating the presence of
a relatively weak internal degron (Fig. 5 E and F). In addition,
∼45% of 35S-labeled Glu16-Bak was degraded before the chase,
in contrast to Val16-Bak (Fig. 5F).
Arg181-Igfbp2. Insulin-like growth factor-binding proteins (IGFBPs)
regulate insulin-like growth factors (IGFs) through interactions
with IGFs that compete with their binding to IGF receptor.
Although a large fraction of IGFBPs is extracellular, these pro-
teins and their fragments have also been detected in the cytosol
and the nucleus (40). The 16-kDa mouse Arg181-Igfbp2 fragment
(Fig. 2, #6 and Fig. S1C) (41) was short-lived in reticulocyte
extract (postpulse t1/2 of ∼5 min), in contrast to Val181-Igfbp2,
which was completely stable (Fig. 5 G and H). In addition, ∼85%
of 35S-labeled Arg181-Igfbp2 was degraded before the chase, in
contrast to Val181-Igfbp2 (Fig. 5).
Glu51-IκBα. IκBα binds to the multifunctional transcriptional reg-
ulator NFκB and retains it in the cytosol. The subunit-selective
and conditional degradation of IκBα in the IκBα-NFκB complex
activates NFκB (42). The degradation of IκBα is mediated by two
pathways, regulated by different inputs. Specifically, phosphory-
lation of IκBα activates its phosphodegron and results in its Ub-
dependent degradation by a pathway distinct from the N-end rule
pathway. IκBα can also be cleaved by calpains, resulting in the 31-
kDa Glu51-IκBα fragment (Figs. 2, #5, and 3C) (43). Mouse
Glu51-IκBα was short-lived in reticulocyte extract (postpulse t1/2
of ∼14 min), in contrast to Val51-IκBα, which was nearly com-
pletely stable (Fig. 5 I and J). In addition, ∼35% of 35S-labeled
Glu51-IκBα was degraded before the chase, in contrast to Val51-
IκBα (Fig. 5J).
Arg91-c-Fos. c-Fos is a part of major transcriptional regulators,
through its interactions with other transcription factors, including
c-Jun. c-Fos can be conditionally destroyed by pathways of the Ub
system that are distinct from the Arg/N-end rule pathway (44).
c-Fos can also be cleaved by calpains, resulting in the 33-kDa
Arg91-c-Fos fragment (Fig. 2, #4, and Fig. S1A) (45). Mouse
Arg91-c-Fos was short-lived in reticulocyte extract, with an initial
postpulse t1/2 of ∼9 min, in contrast to Val91-c-Fos, which was
nearly completely stable (Fig. 5 K and L). In addition, ∼60% of
35S-labeled Arg91-c-Fos was degraded before the chase, in con-
trast to Val91-c-Fos (Fig. 5L).
Autoprocessed Calpain Subunits as N-End Rule Substrates. Both
Ca2+-activated calpain-1 (the catalytic subunit Capn1 plus the
small subunit Capns1) and calpain-2 (Capn2 plus Capns1) can
undergo a limited autoproteolysis (46, 47). These N-terminal trun-
cations of mouse Capn1, Capn2, and Capns1 generate, respectively,
the Leu28-Capn1, Lys10-Capn2, and Asp142-Capns1 fragments, all
of which bear destabilizing N-terminal residues (Figs. 1A, 2, #7, #9,
and 3F and Fig. S1B). Calpain autoproteolysis is illustrated in Fig.
S2D. Purified human calpain-1 was incubated in the presence of
40 μM CaCl2, followed by SDS/PAGE, which revealed the char-
acteristic conversion of full-length Capn1 to a faster-migrating
species (Fig. S2D) (47). The D. melanogaster calpain-B can also be
autoproteolyzed, resulting in the active Asn224-calpain-B fragment
(48) bearing N-terminal Asn, a destabilizing residue (Fig. 1A).
N-terminal autotruncations decrease the levels of Ca2+ re-
quired for half-maximal calpain activity, a finding consistent with
the possibility that autoproteolysis is functionally relevant (49).
In addition, autotruncations of calpains can also occur in living
cells (50). At the same time, other studies presented strong in
vitro arguments that Ca2+-mediated activation of calpains does
not require their autoproteolysis (1, 51). If specific autotruncated
calpain fragments were short-lived substrates of the Arg/N-end
rule pathway, such a finding, in conjunction with the observed
evolutionary conservation of the calpain auto-cleavage sites
and P1′ residues (Fig. 3F and Fig. S1B), would suggest that the
limited autoproteolysis of calpains is functionally relevant.
Leu28-Capn1. Capn1 is the catalytic subunit of calpain-1. The
80-kDa autogenerated human Leu28-Capn1 fragment (Fig. 2, #9,
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and Fig. S1B) (46) was degraded particularly rapidly either during
or shortly after its synthesis (before the chase) in reticulocyte
extract, and was moderately short-lived afterward (postpulse t1/2
of ∼140 min), in contrast to Val28-Capn1, which was nearly
completely stable (Fig. 5 C and D). Approximately 40% of 35S-
labeled Leu28-Capn1 was degraded before the chase, in contrast
to Val28-Capn1 (Fig. 5D).
Asp142-Capns1. Capns1 is the noncatalytic subunit of calpain-1
and calpain-2. The 16-kDa calpain-generated mouse Asp142-
Capns1 fragment (Figs. 2, #7, and 3F) (52) was short-lived in
reticulocyte extract (initial postpulse t1/2 of ∼7 min), in contrast
to Val142-Capns1, which was still unstable but much longer-lived
(t1/2 of ∼45 min; Fig. 5 A and B). In addition, ∼70% of 35S-labeled
Asp142-Capns1 was degraded before the chase, in contrast to
Val142-Capns1 (Fig. 5B).
N-End Rule Substrate Produced by Calpain from a Full-Length Protein.
To probe degradation of a calpain-generated C-terminal frag-
ment in living cells, we analyzed Phe1279-GluN2a. As described
above, this fragment of a subunit of the NMDAR receptor was
rapidly destroyed by the Arg/N-end rule pathway in reticulocyte
extract (Figs. 2, #13, 3D, and 4 B and C). A URT-based pulse-
chase (Fig. 4A) in transfected HEK293T human cells produced
similar results. Specifically, Phe1279-GluN2a was short-lived in
HEK293T cells, in contrast to Val1279-GluN2a (Fig. S2 A and
B). The latter fragment, although not as stable as it was in re-
ticulocyte extract (Fig. 4 B and C), was degraded in vivo much
more slowly (t1/2 > 2 h) than the otherwise identical Phe1279-
GluN2a fragment (initial postpulse t1/2 of ∼15 min; Fig. S2 A and
B). Moreover, and also similarly to the results with reticulocyte
extract, ∼70% of 35S-labeled Phe1279-GluN2a was degraded
before the chase (during the pulse), in contrast to Val1279-
GluN2a (Fig. S2 A and B).
The Arg/N-end rule substrates examined thus far (Figs. 2–5
and Fig. S2A) were produced through the Ub fusion technique,
which makes it possible to form, cotranslationally, specific cal-
pain-generated fragments without using calpains (Fig. 4A). Can
similar results be obtained through the actual calpain-mediated
cleavage of a full-length protein? To address this question, we used
the N-terminally and C-terminally flag-tagged full-length Ica512
(Ptprn) (Figs. 2, #12, and 4 D and E, and Fig. S1D), termed
fIca512f. A mutant (control) derivative of fIca512f, termed fIca512f-
K609V, contained Val, instead ofWT Lys, at the P1′ position 609.
In the plasmids that expressed fIca512f and fIca512f-K609V, the
encoded N-terminal flag was at the position immediately down-
stream of the signal sequence of fIca512f. This arrangement
allowed the retention of N terminus-proximal flag on the natural
processing and transmembrane localization of fIca512f and
fIca512f-K609V in HEK293T cells. Specifically, the flag tag be-
came N-terminal after the ER import of fIca512f and fIca512f-
K609V in HEK293 cells and the removal of their signal sequence
by signal peptidase.
Calpain-based 35S-pulse-chase assays with full-length fIca512f
and fIca512f-K690V were initially performed in reticulocyte ex-
tract. Proteins were synthesized and labeled for 60 min with [35S]
methionine (Fig. 6 B and C). The cleavage of 35S-labeled fIca512f
and fIca512f-K609V was initiated by the addition of CaCl2 and
purified human calpain-1. After 30 min, the calpain inhibitor
z-VF was added, followed by a chase for 30 and 120 min, im-
munoprecipitation with anti-flag antibody, SDS/PAGE, autoradi-
ography, and quantification. The calpain-mediated cleavage
of 35S-fIca512f and fIca512f-K609V reached completion dur-
ing the 30-min incubation with calpain-1 (Fig. 6B, lanes 2 and
6). The relative stabilities of the resulting C-terminal frag-
ments were as would be predicted from assays with Lys609-
Ica512 vs. Val609-Ica512 that had been produced through the Ub
fusion technique. Specifically, the calpain-generated Val609-
Ica512f fragment (produced from full-length fIca512f-K609V) was
completely stable in reticulocyte extract, whereas the otherwise
identical WT Lys609-Ica512f was short-lived (t1/2 of ∼40 min; Fig.
6 B and C). As could be expected, the posttranslationally gen-
erated (from full-length fIca512f) Lys609-Ica512f fragment was
degraded less rapidly than the otherwise identical fragment that
had been cotranslationally produced through the Ub fusion
technique (Fig. 6 B and C vs. Fig. 4 D and E).
To verify membrane localization of fIca512f expressed in
HEK293T cells, their detergent-free extract was fractionated
into soluble cytosol (SC) and membrane (M) fractions. The bulk
of fIca512f was recovered in the insoluble (membrane) fraction
(Fig. S2C). For calpain-based 35S-pulse-chases with fIca512f and
fIca512f-K690V, HEK293T cells expressing these proteins were
Fig. 6. Calpain-mediated generation of Arg/N-end rule substrates. (A) The
N-terminal/C-terminal double tagging of a test protein to enable the de-
tection of both fragments that result from an in vitro or in vivo protein
cleavage. (B) Calpain-mediated generation of the Lys609-Ica512f fragment
from full-length fIca512f and specific degradation of Lys609-Ica512f in re-
ticulocyte extract. Lane 1, the doubly flag-tagged full-length fIca512f protein
was labeled for 60 min with [35S]methionine in reticulocyte extract, followed
by immunoprecipitation with anti-flag antibody, SDS/PAGE, and autoradi-
ography. Lane 2, same as lane 1, but after the addition of CaCl2 and purified
human calpain-1, followed by incubation for 30 min and the addition of the
z-VF calpain inhibitor. Lanes 3 and 4, same as lane 2 but a chase for 30 and
120 min, respectively, before immunoprecipitation with anti-flag antibody
SDS/PAGE, and autoradiography. Lanes 5–8, same as lanes 1–4, respectively,
but with the mutant fIca512f-K609V protein. (C) Quantification of data in B.
(D) Lane 1, HEK293T cells transiently expressing fIca512f were labeled for 60
min with [35S]methionine, followed by protein extraction, immunoprecipi-
tation with anti-flag antibody, SDS/PAGE, and autoradiography. Lane 2,
same as lane 1, but after incubation of 35S-labeled cells for 60 min with
2.5 mM unlabeled L-methionine, 3 mM CaCl2, and 50 μM A23184, a Ca2+ iono-
phore. Lanes 3 and 4, same as lane 2 but a chase for 1.5 and 6 h, respectively,
before immunoprecipitation with anti-flag antibody, SDS/PAGE, and autoradi-
ography. Lanes 5–8, same as lanes 1–4, respectively, but with the mutant
fIca512f-K609V protein (main text). (E ) Quantification of data in D.














labeled for 60 min at 37 °C with [35S]methionine, followed by
a 60-min incubation in the presence of 2.5 mM unlabeled
L-methionine, 3 mM CaCl2, and 50 μMA23184, a Ca2+ ionophore.
The cell-penetrating z-VF calpain inhibitor was then added,
followed by a chase for 1.5 and 6 h, extraction of proteins, im-
munoprecipitation, SDS/PAGE, autoradiography, and quantifi-
cation. The results were similar to those with reticulocyte extract,
except for two differences (Fig. 6 D and E. vs. Fig. 6 B and C).
First, the calpain-mediated cleavage of full-length fIca512f and
fIca512f-K690V was complete in reticulocyte extract but partial
in HEK293T cells. Second, there was a considerable degradation
of the calpain-generated Lys609-Ica512f fragment (in compari-
son with Val609-Ica512f) by the Arg/N-end rule pathway before
the chase in HEK293T cells, similarly to the early-degradation
pattern of Lys609-Ica512 that had been produced through the
Ub fusion technique in reticulocyte extract (Fig. 6 D and E. vs.
Figs. 4 D and E and 6 B and C).
These assays confirmed that the degradation of a calpain-
generated C-terminal protein fragment that had been derived
posttranslationally from a full-length precursor in reticulocyte
extract or HEK293T cells was qualitatively similar to the degra-
dation of the otherwise identical fragment that had been pro-
duced through the Ub fusion technique (Figs. 4–6 and Fig. S2 A
and B). The cotranslationally generated Arg/N-end rule substrate
such as Lys609-Ica512 was degraded faster than the otherwise
identical substrate that had been produced posttranslationally
(Fig. 4 D and E vs. Fig. 6 A–C). These results were consistent
with documented patterns of more efficacious degradation, by
the Arg/N-end rule pathway, of conformationally immature
proteins (9).
Discussion
Previous studies have shown that C-terminal fragments of in-
tracellular proteins that can be generated by separases and cas-
pases often bear destabilizing N-terminal residues. As a result,
these fragments can be recognized and degraded by the Arg/
N-end rule pathway (Fig. 1A) (9–13).
For example, the high fidelity of chromosome cohesion/seg-
regation in S. cerevisiae requires the destruction, by the Arg/
N-end rule pathway, of a C-terminal fragment of the Scc1/Rad21
subunit of cohesin, a protein whose ring-shaped molecules hold
together sister chromatids (10). The cleavage of Scc1, mediated
by a protease called separase, opens the cohesin ring and allows
separation of the chromatids. The normally short-lived C-ter-
minal fragment of Scc1 becomes long-lived in ubr1Δ cells, which
lack the Arg/N-end rule pathway. Ubr1-lacking cells exhibit
a strikingly elevated frequency of chromosome loss. This geno-
mic instability was traced to a long in vivo half-life of the nor-
mally short-lived C-terminal Scc1 fragment, whose increased
levels in ubr1Δ cells impair chromosome mechanics (10).
More recently, we discovered that the Arg/N-end rule pathway
is also a functionally important repressor of apoptosis, through
its ability to destroy and thereby to down-regulate a dozen or
more of specific proapoptotic protein fragments that bear
destabilizing N-terminal residues and are generated by activated
caspases from full-length precursor proteins (11). We also found
that the previously identified, neurodegeneration-associated
C-terminal fragments of Tau, Tdp43, and α-synuclein (these frag-
ments are produced through cleavages by a variety of non-
processive proteases) can be destroyed through their N-degrons,
suggesting that one function of the Arg/N-end rule pathway is to
counteract neurodegeneration (12).
In the present study, the range of physiological Arg/N-end rule
substrates was expanded to include a number of calpain-gener-
ated protein fragments that bear destabilizing N-terminal resi-
dues. We selected, nearly at random, 11 C-terminal fragments of
natural calpain substrates from a larger set of such substrates
whose fragments were predicted to bear N-degrons (Fig. 2 and
the Introduction). All of the examined fragments were found to
be efficacious targets of the Arg/N-end rule pathway. Moreover,
in most of them, their N-degrons were, to a good approximation,
either the sole or major degradation signals (Figs. 2 and 4–6 and
Fig. S2 A and B). Given these results, it is likely that many
(possibly most) of the currently unverified calpain-generated
protein fragments that are classed as predicted N-end rule sub-
strates (Fig. 2, #14–34) will eventually prove to be such on
direct examination.
The set of natural calpain-generated C-terminal protein frag-
ments that have been identified in the present study as short-
lived Arg/N-end rule substrates comprises Phe-GluN2a, the frag-
ment of the subunit of the NMDAR; Lys-Ica512, the fragment of
a receptor protein phosphatase-like protein; Arg-Ankrd2, the frag-
ment of a negative regulator of muscle differentiation; Tyr-Grm1,
the fragment of a metabotropic glutamate receptor; Arg-Atp2b2,
the fragment of a transmembrane pump that ejects Ca2+ from the
cytosol; Glu-Bak, the proapoptotic fragment of an apoptosis regu-
lator; Arg-Igfbp2, the fragment of an insulin-like growth factor-
binding protein;Glu-IκBα, the fragment of the inhibitory subunit of
the IκBα-NFκB complex; Arg-c-Fos, the fragment of a major tran-
scriptional regulator; Leu28-Capn1, the autogenerated, catalytically
active fragment of calpain-1; and Asp142-Capns1, the fragment of
the noncatalytic subunit of calpain-1 (Figs. 2, #1 and #4–13, and
3–6 and Figs. S1 and S2).
Now that a number of functionally diverse proteins have been
identified as precursors of calpain-generated fragments that are
targeted for degradation by the Arg/N-end rule pathway (Figs. 2–
6), the next step is to analyze the fragments themselves, their for-
mation within cognate oligomeric complexes in vivo, the kinetics of
fragments’ degradation under physiologically relevant conditions,
the remodeling of oligomeric complexes in which the fragments
initially reside, and the functional significance of fragments vis-á-vis
specific biological circuits that involve these (and analogous) frag-
ments, as well as corresponding precursor proteins.
One verifiable possibility, stated here in the context of the
IκBα precursor protein (Figs. 2, #5, 3C, and 5 I and J) and likely
to be relevant to other calpain substrates as well, is as follows.
The calpain-mediated cleavage of IκBα, which yields the Glu51-
IκBα fragment and the corresponding N-terminal fragment, may
not suffice, by itself, for a rapid-enough in vivo dissociation of (at
least) the Glu51-IκBα C-terminal fragment from the cleaved
IκBα-NFκB complex. If so, the subunit selectivity of the Arg/
N-end rule pathway (9) that presumably involves a mechanochem-
ical dislodging of the Glu51-IκBα fragment from the cleaved
IκBα-NFκB complex before the fragment’s processive degrada-
tion may be required for an optimal rate of liberation of the
NFκB transcriptional activator. This rate would determine, in
turn, the activity of NFκB circuits that involve the calpain-mediated
cleavage of IκBα.
Both the proven examples above (the fidelity of chromo-
some segregation; the repression of apoptosis) and analogous
but unexamined scenarios, such as the one about the Glu51-
IκBα fragment, imply a mode of action by the Arg/N-end rule
pathway that can recur in a broad variety of contexts. Con-
fining this understanding to calpains, we suggest that the Arg/
N-end rule pathway can use its subunit selectivity (9, 53) to reset the
state of a biological circuit by making possible an efficacious, deg-
radation-mediated replacement of a cleaved subunit by the intact
one in a protein complex that had sustained a calpain-mediated
cleavage. If the efficacy of this subunit’s replacement is a part of
a circuit’s output signal, the rate of degradation of a subunit’s
fragment by the Arg/N-end rule pathway may act as a timer, by
analogy to other relatively slow and irreversible transitions, such
as, for example, the hydrolysis of GTP by G-type proteins that
mediates a variety of functions, from kinetic proofreading in
protein synthesis to receptor desensitization.
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Described in Results and illustrated in Fig. 3 and Fig. S1C
are several examples of the “drift-with-constraint” evolutionary
pattern of P1′ residues in calpain substrates (a P1′ residue be-
comes N-terminal upon cleavage of a polypeptide). For instance,
the evolutionary changes of the P1′ residue in the cleavage site of
Bak, a calpain substrate and regulator of apoptosis, are confined
solely to Glu, Asp, and Lys, all of which are destabilizing residues
(Figs. 1A and 3A). These evolutionary patterns and the meta-
bolic instability of the mouse Glu16-Bak fragment (Fig. 5 E and
F) strongly suggest that the degradation of this calpain-generated
fragment serves to down-regulate its proapoptotic activity. The
instability of proapoptotic Glu16-Bak that has been demon-
strated in the present study is yet another illustration of the
previously discovered function of the Arg/N-end rule pathway in
which it acts as a repressor of apoptosis, by selectively destroying
protease-generated proapoptotic protein fragments, the ones
analogous to but distinct from Glu16-Bak (11).
We also found that the self-cleavages of calpain-1, either of
its catalytic (Capn1) or noncatalytic (Capns1) subunits, yield
C-terminal fragments (catalytically active in the case of Capn1) that
are targeted for degradation by the Arg/N-end rule pathway (Fig. 5
A–D). Thus, the autoprocessing of calpains can control them by
making active calpains short-lived. The activation of calpains under
conditions of traumatic or hypoxic brain injury is accompanied by
the in vivo autoproteolysis of calpain-1 and has been shown to
result in a preferential degradation of the autotruncated cal-
pain-1 (54), the latter finding being in agreement with our data
(Figs. 3F and 5 A–D and Fig. S1B). Given the current un-
certainty about biological roles of catalytically active calpain
fragments (Results), key questions for future studies in this do-
main include the extent of calpain autoproteolysis in vivo under
normal or stressful conditions; the contribution of resulting
calpain fragments to the overall proteolytic activity of a specific
calpain; and the role of the Arg/N-end rule pathway in the
degradation of natural calpain fragments.
Both our findings and the earlier understanding of the dynamics
of protein fragments vis-à-vis the Arg/N-end rule pathway (7, 9, 12,
14, 23) indicate that the topologically unique nature of N-degrons
(their main determinant is a single N-terminal residue) has sig-
nificantly contributed to coevolution of nonprocessive proteases
and their cleavage sites in cellular proteins. As described above,
these cleavage sites tend to be conserved in evolution, and their
P1′ residues often yield C-terminal fragments whose N-terminal
residues are recognized by the Arg/N-end rule pathway (Figs. 1A,
2, 4, and 5). Moreover, although the exact identity of a P1′ residue
in a cleavage site can change during evolution, the residue’s
destabilizing nature is virtually always retained (Fig. 3 and Fig. S1),
suggesting that a short in vivo half-life of a fragment (rather than
the exact identity of its N-terminal residue) is a fitness-increasing
property of this fragment, favored by natural selection.
In sum, the degradation of protease-generated protein frag-
ments by the Arg/N-end rule pathway (Fig. 1A) has been identified
as a significant part of cellular regulation. Examples, in addition to
the present results (Figs. 1–6), include the aforementioned main-
tenance of the fidelity of chromosome cohesion/segregation and
the function of the Arg/N-end rule pathway in repressing apoptosis
and neurodegeneration (10, 12, 14). Another example is the con-
trol of error-prone DNA synthesis, a part of DNA damage re-
sponse. The Usp1 deubiquitylase (its functions include the
control of DNA replication through unrepaired DNA lesions) can
cleave itself but remains, transiently, an active deubiquitylase, as
the two fragments of self-cleaved Usp1 stay together for some time
(14, 55). The C-terminal fragment of the self-cleaved Usp1 has
been shown to be a short-lived physiological substrate of the Arg/
N-end rule pathway (14). The rate of processive degradation of
this fragment may act as a timer that determines the rate of ces-
sation of deubiquitylation by self-cleaved Usp1.
An Nt-acetylated protein fragment is a potential target of the
Ac/N-end rule pathway (Fig. 1B) (23, 24). An Nt-acetylated
N-terminal fragment can be produced posttranslationally, by
a calpain or another nonprocessive protease upon cleavage of a
cotranslationally Nt-acetylated full-length protein. This cleavage
would also yield a C-terminal fragment, the one that can be rec-
ognized and degraded by the Arg/N-end rule pathway, as de-
scribed in the present study (Figs. 2–6). In addition, a C-terminal
fragment bearing an N-terminal residue that is permissive for Nt-
acetylation (25) may be posttranslationally Nt-acetylated and
thereby become a substrate of the Ac/N-end rule pathway. The
latter possibility remains to be addressed experimentally.
The ability of the Arg/N-end rule and Ac/N-end rule path-
ways (Fig. 1) to target proteins for degradation by recognizing
their destabilizing N-terminal residues is a unique attribute of
these pathways vis-à-vis the rest of the Ub system. This capability,
in conjunction with the subunit selectivity of proteolysis by the
N-end rule pathway (9, 53), plays a major role in protein remod-
eling through the selective elimination of protein fragments from
oligomeric complexes in which these fragments are generated and
transiently reside. Nonprocessive intracellular proteases that
produce such fragments include calpains, caspases, separases,
and secretases. The regulated destruction of protein fragments
is likely to underlie a number of diverse biological functions of
the N-end rule pathway that are cited in the Introduction. Many
of these functions have been discovered through genetic (non-
mechanistic) approaches. Fragments produced through cleav-
ages by calpains are a major part of natural protein fragments
under both normal and stressful conditions. The present results
will facilitate the functional understanding of the striking diversity
of calpain-generated fragments in the context of the N-end rule
pathway (Fig. 2 and Introduction). Most of these fragments are
still understood in descriptive (nonfunctional) terms.
Materials and Methods
Plasmids, cDNAs, and Primers. URT-based plasmids and other plasmids, con-
structedby standardmethods, aredescribed inTable S1. PCRprimers aredescribed
in Table S2. Specific cDNAs encoding test proteins of the present studywere either
amplified from mouse cDNA libraries or purchased from Open Biosystems.
In Vitro and in Vivo Degradation Assays. The in vitro transcription-translation-
degradation assays used the TNT T7 Coupled Transcription/Translation Sys-
tem (Promega) (11). Human HEK293T cells were transfected with specific
plasmids using Lipofectamine-2000 (Invitrogen).
These and other technical details of the present study are described in
SI Materials and Methods.
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